The first plant polymer-based TLR4 agonist, inulin acetate, which is synthesized from plant polysaccharide inulin [105], has been reported to induce strong systemic and mucosal immunity [106] and may be useful in the development of a COVID-19 vaccine. Here, TLR4 is linked to COVID-19.